Skip to content
healthcare.dev

Repaglinide

NDC 62135-946, Repaglinide, tablet, from Chartwell RX, LLC.

Product NDC
62135-946
Status
Listed
Labeler
Chartwell RX, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA078555
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62135-946 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • REPAGLINIDE.5 mg/1

Pharmacologic classes

Glinide [EPC]; Potassium Channel Antagonists [MoA]

Package NDCNDC-11Package
62135-946-906213509469090 TABLET in 1 BOTTLE (62135-946-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/cb995e92-295e-4638-a064-978211f5afe1
  • NADAC price for package 62135094690

    GET /v1/drugs/nadac/62135094690

Use it

Look up 62135-946 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62135-946 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62135-946. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.